Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Siemens    SIE   DE0007236101

SIEMENS (SIE)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Siemens AG : WSJ BLOG/Health : Siemens Sees Resurgence in Diagnostics as a Cost Cutter

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/13/2012 | 07:02pm CEST

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Shirley S. Wang

The Health Blog caught up at TEDMED with Gregory Sorensen, chief executive of Siemens Healthcare in North America, to talk about the changing health-care field and what it means for diagnostics, an area in which Siemens is a player.

"We're beginning to see resurgence in diagnostics as a way to save costs, " Sorensen, formerly a radiology professor at Harvard Medical School, told the Health Blog.

A missed diagnosis is a big cost driver in health care because it wastes time and money on ineffective therapy, he said, pointing to an example of studies in Alzheimer's showing that upon autopsy, some 15%-20% of patients examined had a different ailment than believed and would have been treated differently when they were alive.

Of course, there's been an outcry about the unnecessary use of medical tests and Sorensen acknowledges there has been overuse in the past. Reductions in Medicare reimbursement rates have curbed overuse, he says, though not everyone agrees on that, as the Health Blog reported last week. The important thing now, Sorensen says, is to make sure people are getting the right diagnostic tests, rather than reduce the absolute number of them.

He recalled being a doctor in training in the late 1980s, when his professors taught him that, because of the risks associated with appendicitis, doctors should be conservative whenever a patient reported pain in the lower right quadrant of the abdomen. A good surgeon, therefore, would do exploratory surgery on five patients for every one that actually had appendicitis. Sorensen himself had his appendix -- which turned out to be healthy -- removed during this era.

Now patients get scanned if they report such pain, resulting in many fewer unnecessary surgeries, said Sorensen.

Siemens recognizes how important it is to demonstrate effectiveness in today's health-care business, and that payers want to see results, says Sorensen. As for the shift to reimbursement for value, "that train has left the station."

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SIEMENS
06:54aSIEMENS : plans $500m Middle East expansion
AQ
04/24SIEMENS : wins prize for outstanding inclusion of employees with disabilities
PU
04/24SIEMENS TURNS THE INDUSTRIE 4.0 VISI : 'Digital Enterprise - Implement now!'; Th..
AQ
04/24SIEMENS : More Companies Are Selling Assets to Raise Cash for Growth
DJ
04/24PHOTO NEWS RELEASE : Aliko Dangote visited Siemens Africa Booth at the ongoing H..
AQ
04/23PHOTO NEWS RELEASE : Aliko Dangote visited Siemens Africa Booth at the ongoing H..
AQ
04/23SIEMENS : turns the Industrie 4.0 vision into reality with its Digital Enterpris..
PU
04/23SIEMENS AKTIENGESELLSCHAFT : Release of a capital market information
EQ
04/23Siemens CEO says rail business performed well in Q2
RE
04/23Germany's VDMA raises 2018 output growth forecast to 5 percent
RE
More news
News from SeekingAlpha
04/20A Good Start To The Year For ABB, But Management Has To Build From Here 
04/17One Critical Issue Makes GE A Strong Buy 
04/11ROAD TO FINANCIAL INDEPENDENCE : My March 89-Stock Portfolio Review 
03/26Siemens Aktiengesellschaft (SIEGY) Presents At Bank Of America Merrill Lynch .. 
03/16What GE And Tesla Now Have In Common, And A Better Investment In The Field 
Financials (€)
Sales 2018 83 985 M
EBIT 2018 7 890 M
Net income 2018 5 702 M
Debt 2018 17 381 M
Yield 2018 3,58%
P/E ratio 2018 15,32
P/E ratio 2019 13,92
EV / Sales 2018 1,30x
EV / Sales 2019 1,24x
Capitalization 92 208 M
Chart SIEMENS
Duration : Period :
Siemens Technical Analysis Chart | SIE | DE0007236101 | 4-Traders
Technical analysis trends SIEMENS
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 131 €
Spread / Average Target 23%
EPS Revisions
Managers
NameTitle
Josef Kaeser President & Chief Executive Officer
Jim Hagemann Snabe Chairman-Supervisory Board
Ralf Peter Thomas Chief Financial Officer
Roland Emil Busch Chief Technology Officer
Helmuth Ludwig Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
SIEMENS-8.50%112 627
3M COMPANY-8.28%128 386
GENERAL ELECTRIC COMPANY-16.79%126 085
HONEYWELL INTERNATIONAL-3.09%111 009
ILLINOIS TOOL WORKS-6.14%53 481
JARDINE MATHESON HOLDINGS LIMITED0.74%44 665